trending Market Intelligence /marketintelligence/en/news-insights/trending/KQCkOpOHXiIo3JFn2OH3tg2 content esgSubNav
In This List

Nephros receives US FDA marketing clearance for HydraGuard system

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Nephros receives US FDA marketing clearance for HydraGuard system

Nephros Inc. received 510(k) clearance from the U.S. FDA for its HydraGuard 10" UltraFilter, a system for use with a hemodialysis machine for the treatment of patients with end stage renal disease.

The product is designed to provide hospitals and medical facilities with a long-term solution to protect patients from bacteria that may be present in the potable water systems.